SPRY CapEx to Revenue

Ars Pharmaceuticals Inc · CapEx to Revenue

SPRY logo

SPRY CapEx to Revenue

Current (TTM)0.17%
SPRY CapEx/Revenue (0.00% → 0.17%)
High-resolution chart · PNG

SPRY capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Ars Pharmaceuticals Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.4022%
0.6315%
583.3333%
15.1216%
0.9989%
5.1416%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.